Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Briacell Therapeutics Corp T.BCT

Alternate Symbol(s):  BCTX | BCTXW

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. Bria-IMT, its Phase 3 lead candidate, is a patented, off-the-shelf, cell-based, targeted immunotherapy that activates the patient’s immune system to specifically kill cancer cells without harming other cells. The Company is advancing its Bria-IMT targeted immunotherapy in combination with an immune check point inhibitor (Retifanlimab) in a pivotal Phase 3 study in metastatic breast cancer. It is also developing personalized off-the-shelf immunotherapies, Bria-OTS and Bria-OTS+, which provides a platform technology to develop personalized off-the-shelf immunotherapies for numerous types of cancer, and a soluble CD80 protein therapeutic which act both as a stimulator of the immune system, as well as an immune checkpoint inhibitor. Its pipeline also includes Bria-IMT + CPI, Bria-BRES/BRES+, Bria-PROS+, Bria-LUNG+ and Bria-MEL+.


TSX:BCT - Post by User

Bullboard Posts
Comment by PoorOpinionon Sep 27, 2018 11:48am
49 Views
Post# 28701393

RE:We Now Have.. 'PROOF OF CONCEPT'

RE:We Now Have.. 'PROOF OF CONCEPT'
KewlNewf wrote: Having listened to many CEO's of successful global companies, I have noticed they all acknowledge a common thread throughout... 'It all starts with, 'Proof of Concept' ..


In one sense you're right, Proof of concept is extremely important so its worth looking at that critically when a management makes such a claim.

What we have is some limited data that fits with a certain hypothesis. Its fine for management to tout this as a 'proof of concept' but what it really means is it validates going forward with their  'OTS' approach. The real 'proof of concept' in my mind will come when they have the OTS products up and running and can show that targeting each patient with the correct matching product improves clinical outcomes. The results yesterday are certainly very promising but I'd be more demanding and say we're not quite there yet in terms of proof of concept.
Bullboard Posts